Exane BNP Paribas analyst Hugo Solvet fouble upgraded Sonova to Outperform from Underperform with a price target of CHF 285, up from CHF 195. An 18 month earnings downgrade cycle is coming to an end as Sonova is seeing accelerating momentum ahead of a new product cycle, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SONVY:
